The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities

The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities

Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are two chronic cholestatic liver diseases affecting bile ducts that may progress to biliary cirrhosis. In the past few years, the increasing knowledge in the pathogenesis of both diseases led to a growing number of clinical...

Full description

Bibliographic Details
Main Authors: Marta Mazzetti, Giulia Marconi, Martina Mancinelli, Antonio Benedetti, Marco Marzioni, Luca Maroni
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
clinical trials
ursodeoxycholic acid (UDCA)
Farnesoid X Receptor (FXR) agonist
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
Online Access:https://www.mdpi.com/2077-0383/10/8/1763

Internet

https://www.mdpi.com/2077-0383/10/8/1763

Similar Items